---
document_datetime: 2026-01-16 16:59:06
document_pages: 4
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/namuscla-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: namuscla-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 2.9832355
conversion_datetime: 2026-01-17 13:04:23.0014
docling_version:
  docling-serve: 1.10.0
  docling-jobkit: 1.8.1
  docling: 2.68.0
  docling-core: 2.59.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.3
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Namuscla

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                          | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IB/0012              | C.I.3.z - Change(s) in the SPC, Labelling or PL intended to implement the outcome of a procedure concerning PSUR or PASS or the outcome of the assessment done under A 45/46 - Other variation | 20/02/2023                          |                                             | Annex II                         |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IB/0011             | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                                                                                                                                                                                                                           | 29/11/2022   | n/a   |                                   |
|---------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-----------------------------------|
| PSUSA/10738 /202112 | Periodic Safety Update EU Single assessment - mexiletine (centrally authorised products only)                                                                                                                                                                                                                                                                                                                                                                                                                           | 07/07/2022   | n/a   | PRAC Recommendation - maintenance |
| IA/0010/G           | This was an application for a group of variations. B.III.1.b.3 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Updated certificate from an already approved manufacturer B.III.1.b.3 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Updated certificate from an already approved manufacturer                                                                                                                                            | 10/05/2022   | n/a   |                                   |
| IA/0009/G           | This was an application for a group of variations. B.III.1.b.2 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - New certificate for a starting material/reagent/intermediate/or excipient from a new or an already approved manufacturer B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer B.III.1.b.3 - Submission of a new/updated or | 02/05/2022   | n/a   |                                   |

<div style=\"page-break-after: always\"></div>

|                     | manufacturer B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer B.III.1.b.4 - Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Deletion of certificates (in case multiple certificates exist per material)   |            |            |              |                                   |
|---------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|--------------|-----------------------------------|
| PSUSA/10738 /202012 | Periodic Safety Update EU Single assessment - mexiletine (centrally authorised products only)                                                                                                                                                                                                                                                                                             | 08/07/2021 | n/a        |              | PRAC Recommendation - maintenance |
| PSUSA/10738 /202006 | Periodic Safety Update EU Single assessment - mexiletine (centrally authorised products only)                                                                                                                                                                                                                                                                                             | 14/01/2021 | n/a        |              | PRAC Recommendation - maintenance |
| PSUSA/10738 /201912 | Periodic Safety Update EU Single assessment - mexiletine (centrally authorised products only)                                                                                                                                                                                                                                                                                             | 09/07/2020 | n/a        |              | PRAC Recommendation - maintenance |
| IB/0005             | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                                                                                             | 25/06/2020 | n/a        |              |                                   |
| N/0004              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                          | 21/04/2020 | 13/07/2020 | PL           |                                   |
| PSUSA/10738 /201906 | Periodic Safety Update EU Single assessment - mexiletine (centrally authorised products only)                                                                                                                                                                                                                                                                                             | 16/01/2020 | n/a        |              | PRAC Recommendation - maintenance |
| IAIN/0001/G         | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                                                        | 17/07/2019 | 13/07/2020 | Annex II and |                                   |

<div style=\"page-break-after: always\"></div>

| A.7 - Administrative change - Deletion of manufacturing sites B.III.1.a.1 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - New certificate from an already approved manufacturer   | PL   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------|